Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo’s Pending OTC Launches Promising But Pandemic Precludes Pumping Guidance

Aug 05 2020

• By Eileen Francis

Quarterly resluts on typewriter close up

Related Content

No Decisions Yet In Perrigo's Disputes With Ireland, US Over Tax Questions From Elan Merger

Aug 05 2020

Perrigo Takes $50M Step For US Consumer Health Industry Into CBD, Invests In Supplier Kazmira

Jun 17 2020

Perrigo Feeds OTC Brand Play With Prevacid As GSK Thins Consumer Lineup

Sep 05 2019

'Positive' Signs Abound For Perrigo, But 'Uncertainty' From Pandemic Complicates Outlook

May 01 2020

Perrigo Has Approval For Copy Of OTC Voltaren Arthritis Relief Before GSK Launches The Brand

Apr 07 2020

Perrigo Moves Closer To Exclusive Consumer Focus With UK Rx Generics Business Sale

Jun 23 2020

Related Companies

Perrigo Company PLC

GSK plc

Additional Topics

International Ireland Europe United States Commercial Sales & Earnings OTC Drugs Advertising, Marketing & Sales Business Strategies Companies Coronavirus COVID-19 Deals Dietary Supplements Ingredients Manufacturing Launches Consumer Pipeline Watch

More from Business

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window